A detailed history of Emerald Advisers, LLC transactions in Quanterix Corp stock. As of the latest transaction made, Emerald Advisers, LLC holds 719,217 shares of QTRX stock, worth $8.97 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
719,217
Previous 680,987 5.61%
Holding current value
$8.97 Million
Previous $9 Million 3.54%
% of portfolio
0.39%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$10.92 - $16.36 $417,471 - $625,442
38,230 Added 5.61%
719,217 $9.31 Million
Q2 2024

Aug 06, 2024

SELL
$12.26 - $23.78 $299,879 - $581,658
-24,460 Reduced 3.47%
680,987 $9 Million
Q1 2024

May 08, 2024

BUY
$21.9 - $28.28 $2.87 Million - $3.7 Million
130,993 Added 22.8%
705,447 $16.6 Million
Q4 2023

Feb 05, 2024

BUY
$19.54 - $28.66 $3.69 Million - $5.42 Million
188,958 Added 49.02%
574,454 $15.7 Million
Q3 2023

Oct 26, 2023

BUY
$21.15 - $27.96 $8.15 Million - $10.8 Million
385,496 New
385,496 $10.5 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $461M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.